Sopharma AD
No trades
No trades
Compare with Sopharma AD
0.150 EUR
66.03 M EUR
1.33 B EUR
399.85 M
Details
Sector
Industry
CEO
Ognian Ivanov Donev
Website
Headquarters
Sofia
Founded
1933
IPO date
Jan 20, 1998
ISIN
BG11SOSOBT18
FIGI
BBG000BRBQZ9
Identifiers
ISIN BG11SOSOBT18
Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of SFA is 1.940 EUR — it hasn't changed in the past 24 hours. Watch Sopharma AD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSESOF exchange Sopharma AD stocks are traded under the ticker SFA.
SFA stock has risen by 1.04% compared to the previous week, the month change is a 1.84% rise, over the last year Sopharma AD has showed a 53.00% increase.
Today Sopharma AD has the market capitalization of 1.03 B, it has increased by 1.60% over the last week.
Yes, you can track Sopharma AD financials in yearly and quarterly reports right on TradingView.
SFA net income for the last quarter is 31.70 M EUR, while the quarter before that showed 9.40 M EUR of net income which accounts for 0.00% change. Track more Sopharma AD financial stats to get the full picture.
Yes, SFA dividends are paid semi-annually. The last dividend per share was 0.05 EUR. As of today, Dividend Yield (TTM)% is 5.00%. Tracking Sopharma AD dividends might help you take more informed decisions.
Sopharma AD dividend yield was 1.78% in 2025, and payout ratio reached 50.42%. The year before the numbers were 2.68% and 33.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sopharma AD EBITDA is 108.69 M EUR, and current EBITDA margin is 7.60%. See more stats in Sopharma AD financial statements.
Like other stocks, SFA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sopharma AD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sopharma AD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sopharma AD stock shows the strong buy signal. See more of Sopharma AD technicals for a more comprehensive analysis.